Well, this looks promising, but it wont take long till ACA makes this unheard. Just like with Royal Rife. I just hope it wont happen and DCA will be the cure for cancers.
Metformin may well be another valid way to attach cancer's energy supply and it also acts against mTOR. It reduces blood glucose levels, and sugar is cancer's energy supply. Ironically, DCA was studied to reduce lactic acidosis in newborns, while Metformin can actually cause lactic acidosis. Metformin simply must be pursued in studies with DCA.
Add the generic drug Metformin to the mix, preferably in rats. It was recently found that it reduced breast cancer rates in women who were on it for their diabetes. In a rodent study, it reduced lung cancer rates by 40 and 70% vs controls. Animals were started on the drug, one group with pill, one with shot version and one control, then all were injected with lung cancer. The pill version had the ,,as I recall, 40% reduction and 70% for the shot version of Metformin.
1- In the group mentioned, did the DCA appear to inhibit growth only while it was taken(pushing back the progression by 18 months and then the unfortunate progression starts again) or do the effects last behond this so far?
2- Although the 18-month study is over(?), are/were the patients still taking DCA afterwards?
3- Will the trial patients progression be known to researchers as months and hopefully years go by?
very good and inspiring information.
gadionson1 2 months ago
Well, this looks promising, but it wont take long till ACA makes this unheard. Just like with Royal Rife. I just hope it wont happen and DCA will be the cure for cancers.
TheSteems 8 months ago
Metformin may well be another valid way to attach cancer's energy supply and it also acts against mTOR. It reduces blood glucose levels, and sugar is cancer's energy supply. Ironically, DCA was studied to reduce lactic acidosis in newborns, while Metformin can actually cause lactic acidosis. Metformin simply must be pursued in studies with DCA.
prime3end 1 year ago
Add the generic drug Metformin to the mix, preferably in rats. It was recently found that it reduced breast cancer rates in women who were on it for their diabetes. In a rodent study, it reduced lung cancer rates by 40 and 70% vs controls. Animals were started on the drug, one group with pill, one with shot version and one control, then all were injected with lung cancer. The pill version had the ,,as I recall, 40% reduction and 70% for the shot version of Metformin.
prime3end 1 year ago
1- In the group mentioned, did the DCA appear to inhibit growth only while it was taken(pushing back the progression by 18 months and then the unfortunate progression starts again) or do the effects last behond this so far?
2- Although the 18-month study is over(?), are/were the patients still taking DCA afterwards?
3- Will the trial patients progression be known to researchers as months and hopefully years go by?
Rickdeckard2020 1 year ago 2